MarketInOut Stock Screener Log In | Sign Up

Valiant Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Valiant Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization6,878.68 mln
Float12.62 mln
Earnings Date11/02/2026

EPS

2.75
Stretched

P / E

46.51
High premium

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.46
Borderline

Relative Strength

75 / 100
Strongly outperforming

Debt / Equity

0.15
Very low leverage

Business Description

Founded over four decades ago and headquartered in Mumbai, Valiant Laboratories Limited produces paracetamol and specialty chemicals for customers in India and around the world. The company supplies paracetamol across multiple quality standards, making it suitable for relieving common ailments such as headaches, fever, and joint pain. It operates as part of the Dhanvallabh Ventures group.

Key Fundamentals

EPS2.75
P/E46.51
ROE5.57
RPS56.33
ROIC5.22
ROA3.72
Interest Cover8.60
EBITDA, mln358
EV / EBITDA19.59
EV / EBIT25.57
Revenue, mln3,059
EV / Revenue2.29

Quote Details

Last 127.90
Change -0.35 (-0.27%)
Open 128.25
Volume 1,250
Turnover 159,875
Average Volume 7,630.43

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio1.91
Price / Book2.17
Price / Tangible Book2.17
Debt / Equity0.15
Price / Sales2.18

Financial Strength

Altman Z-Score3.97
Piotroski F-Score 3 / 9
Beneish M-Score-2.46
Price to Graham Number2.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.04% 37 / 100   
1 Month 4.84% 88 / 100   
2 Months 105% 99 / 100   
6 Months 68.29% 95 / 100   
1 Year 45.34% 91 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog